Forty-two subjects with acute tularemia were studied for the occurrence of C-reactive protein (CRP), and 73 subjects with acute tularemia or experience of the disease within the last 11 years were studied for immunoglobulin M (IgM), IgA, and IgG class-specific antibodies, agglutinating antibodies, and complementfixing antibodies to Francisella tularensis by using an enzyme-linked immunosorbent assay (ELISA), the tube agglutination test, and a complement-fixing ELISA. The incubation time between infection and the outbreak of symptoms varied from 1 to 10 days, averaging 6.5 days. Elevated 
The humoral immune responses to Francisella tularensis are well known as far as agglutinating antibodies are concerned, due to the masterly studies by Francis and Evans (7) and Ransmeier and Ewing (23) . These authors demonstrate that agglutinins appear in the second week of illness, reach their maximum in the fourth to the seventh week, and, despite a decreasing trend, are still detectable over 10 years later. Cell-mediated immune responses are also demonstrable years and even decades after tularemia (1, 12) .
Immunoglobulin M (IgM) IgA, and IgG class antibodies to F. tularensis are all very long lasting, and their presence has been shown by enzyme-linked immunosorbent assay (ELISA) years after tularemia infection and also after vaccination (2, 13) . Thus, humoral immunity to F. tularensis seems to be exceptional among infectious diseases.
To obtain more exact information on humoral tularemia immunity, we determined the presence of IgG, IgM, and IgA antibodies to F. tularensis at various intervals after the onset of tularemia, during a follow-up period extending from the first day of illness to 11 years after disease and studied the ability of the antibodies to agglutinate bacteria and to activate complement. The occurrence of C-reactive protein (CRP) in tularemia was also studied, since this has been found in increased amounts in the serum of patients with a wide variety of diseases associated with active inflammation or tissue destruction, including bacterial infections (see reference 22) , and elevated levels of CRP can thus be expected in acute tularemia. MATERIALS against antigen-sensitized wells treated with 4% PBS-Tween, antisera, substrate, and 2 N NaOH. The levels of antibodies in the sample are given as ELISA titers (5, 11) read at optical density values of 0.3 for IgG and 0.1 for both IgM and IgA limits derived from the mean plus two standard deviations of absorbances recorded at a dilution of 1:100 in 60 control sera without agglutinating antibodies. Titers below 100 were regarded as negative.
CF-ELISA. Complement-fixing antibodies were determined by using CF-ELISA, a complement-fixing modification of ELISA (P. Koskela, Vaccine, in press). The sera, complement, and enzyme conjugate were diluted in 4% PBS-Tween, and the diluted sera were inactivated before the test (30 min at 56°C). Fresh human AB serum without antibodies to F. tularensis was used as a source of complement, and alkaline phosphatase-labeled anti-human C3c was used as conjugate. The incubation time for the serum samples, complement, and enzyme-labeled antisera was 1 h. In all other respects, the procedure was similar to that for ELISA. The CF-ELISA titers were read at an absorbance of 0.1, and titers below 100 were regarded as negative.
Tube agglutination. The agglutinating antibodies were determined by using a Widal bacterial agglutination test, as initially described for tularemia by Francis and Evans (7).
Serial twofold dilutions of the sera, starting from 1:5, were prepared in PBS (pH 7.2). Tubes containing 0.5 ml of this and an equal amount of a standardized suspension of Formalin-killed whole bacteria (National Bacteriological Laboratory, Stockholm, Sweden) were incubated overnight (20 h) at 37°C. The antibody titers were expressed as the reciprocal of the highest dilution giving visible agglutination with a clear supernatant, and titers below 10 were considered as negative.
CRP determination. CRP was measured by the Mancini single immunodiffusion method (LC-Partigen-CRP, Behringwerke AG, Marburg, Federal Republic of Germany) with a minimum detectable concentration of 1 mg/liter. CRP measurements below this value were regarded as negative or normal.
RESULTS
Incubation time and certain clinical aspects. The incubation time, i.e., the delay between infection and outbreak of symptoms, varied from 1 to 10 days, averaging 6.5 days. The delay between the onset of symptoms and the seeking of treatment ranged from 1 to 45 days, averaging 7 days, whereas that between the onset of symptoms and the first serum sample for tularemia antibodies varied from 1 to 63 days, being 15 days on average. Serological diagnosis of tularemia took place at 4 to 45 days (20 days on average) after the onset of disease.
The fever generally vanished in 2 weeks, and the lymphadenopathy vanished in 5 weeks. Despite adequate antibiotic treatment, two patients with ulceroglandular and glandular tularemia suffered from a persistent fever for 10 weeks and still had enlarged axillary lymph nodes 8 months afterwards. Diseased muskrats in spring (April through May) had served as the source of infection for these patients.
CRP. Elevated levels of CRP, with a range of 14 to 165 mg/liter and a mean of 49.3 mg/liter, were found in all patient sera during the first 6 days of tularemia ( Fig. 1) , at a time when the antibodies to F. tularensis were undetectable (Table 1 ; Fig. 2 ), but then CRP decreased rapidly. About half of the patients had a normal CRP value at 11 to 20 days, and from 1 month, all the measurements were negative for CRP (Fig. 1) . In all cases, the highest CRP values were observed in the first serum sample, a decrease setting in from the second samples onwards.
Antibodies. Individual differences were observed in the immunization time and the level and persistence of the antibodies appearing 6 to 10 days after the onset of symptoms in most patients, i.e., about 2 weeks after infection.
The earliest IgG class antibodies were found on the first day of tularemia, and the latest ones appeared 12 days after the onset of symptoms. The corresponding ranges for IgM, IgA, and agglutinating antibodies were 2 to 14 days, 2 to 18 days, and 4 to 11 days, respectively, and 4 to 11 days for complement-fixing antibodies.
IgM antibodies occurred in 18.2% of the samples in the first 5 days of tularemia, IgA antibodies occurred in 9.1%, and IgG antibodies occurred in 36.4%. The corresponding frequencies for days 6 to 10 were 75.0, 58.3, and 91.7%, respectively (Table 1 ), the differences in these frequencies being without statistical significance in the chi-square test.
In 23 subjects, the number of serum samples and the duration of the follow-up period were sufficient to show the timing of the maximal antibody levels. The With these exceptions, the ELISA and agglutination test findings were parallel. In no case was CF-ELISA positive earlier than ELISA or the agglutination test.
DISCUSSION
CRP is synthesized by hepatocytes (10) and is a normal trace constituent in the serum, occurring in concentrations of 0.070 to 0.580 mg/liter in healthy individuals (4). Increased CRP levels have been found in various diseases with active inflammation or tissue destruction, including bacterial infections (see reference 22) . The maximum CRP values in the tularemia patients (14 to 165 mg/liter) were observed in the first serum samples, taken during the first few days of the disease, at a time when antibodies to F. tularensis were absent. By far the highest CRP levels, however', occurred earlier on, since CRP decreased in the later samples.
CRP binds specifically to a variety of substances originating from microbes or damaged autologous cells (8, 21, 28, 29) , and complexed CRP will potentially activate complement (classical pathway), mediating complement-dependent adherence (20, 25) . Thus, CRP may generate a protective mechanism which acts before specific immunity has developed. According to Pepys (22) the main role of CRP, however, may be to recognize toxic autogenous materials in the plasma when these have been released from damaged tissues, to bind and detoxify them, and to facilitate their clearance. The CRP concentration in serum is higher in severe forms of tularemia than in milder forms, and it tends to be higher in pulmonary tularemia than in the ulceroglandular type (H. Syrjala, unpublished data). In these respects, it-differs from specific antibodies, which show no difference in level between different clinical forms or severities of tularemia (H. Syrjala, P. Koskela, T. Ripatti, A. Salminen, and E. Herva, J. Infect. Dis., in press).
The IgM, IgA, and IgG antibodies induced by F. tularensis infection generally occurred simultaneously, as also observed in the various clinical types and severities 'of the disease (Syrjala et al., in press) and after vaccination (13 antibodies generally concern primary immune responses and vanish within some months after contact between the immune mechanism and the causative agent, as is mostly the case in acquired toxoplasmosis (9) . IgM antibodies occasionally may be present for years after the acute stage of toxoplasmosis (9), however, as has also occurred after rubella infection (18, 26) . Long-lasting IgM have also been found after Japanese encephalitis (6) and yellow fever vaccination (19) . The mechanism stimulating the continuous formation of IgM, IgA, and IgG is unknown at present, but it may be that intracellular F. tularensis bacteria or their structures remain in the host for a long time, boosting humoral and cellmediated immunity persisting for years after natural tularemia (12) or vaccination (13) .
Antibody classes differ greatly in their ability to fix complement (15) (16) . These data give us reason to assume that antibodies with complement-fixing activity in the humoral immune system provide a better protection against tularemia than those without complement-fixing activity.
Moreover, the role of cell-mediated immunity is most important in resistance to F. tufigrensis (3, 14, 27 
